Tech Company Financing Transactions

BioAge Labs Funding Round

Sofinnova Ventures, Amgen Ventures and Andreessen Horowitz participated in a $170 million Series D funding round for BioAge Labs. The financing round closed on 2/13/2024.

Transaction Overview

Company Name
BioAge Labs
Announced On
2/13/2024
Transaction Type
Venture Equity
Amount
$170,000,000
Round
Series D
Investors

Sofinnova Ventures (Lead Investor) (James Healy)

Amgen Ventures

Andreessen Horowitz (Vijay Pande)

Cormorant Asset Management

Lilly Ventures

Longitude Capital Management (Patrick Enright)

OrbiMed

Osage University Partners

Pivotal bioVenture Partners

RA Capital

RTW Investments

Sands Capital Management

SV Health Investors

Proceeds Purpose
The company intends to use the funds to advance Phase 2 clinical trials of azelaprag, an apelin receptor (APJ) agonist, in combination with Lilly's Zepbound (tirzepatide) and therapeutic pipeline.

Company Information

Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
1445A S 50th St.
Richmond, CA 94804
USA
Phone
Undisclosed
Website
www.bioagelabs.com
Email Address
[email protected]
Overview
We couple omics data with machine learning to measure human aging and accelerate drug discovery.
Profile
BioAge Labs LinkedIn Company Profile
Social Media
BioAge Labs Company Twitter Account
Company News
BioAge Labs News
Facebook
BioAge Labs on Facebook
YouTube
BioAge Labs on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kristen Fortney
  Kristen Fortney LinkedIn Profile  Kristen Fortney Twitter Account  Kristen Fortney News  Kristen Fortney on Facebook
Chief Marketing Officer
Paul Rubin
  Paul Rubin LinkedIn Profile  Paul Rubin Twitter Account  Paul Rubin News  Paul Rubin on Facebook
Chief Operating Officer
Eric Morgen
  Eric Morgen LinkedIn Profile  Eric Morgen Twitter Account  Eric Morgen News  Eric Morgen on Facebook
Chief Scientific Officer
Klaus Klumpp
  Klaus Klumpp LinkedIn Profile  Klaus Klumpp Twitter Account  Klaus Klumpp News  Klaus Klumpp on Facebook
Controller
Ralph Scarborough
  Ralph Scarborough LinkedIn Profile  Ralph Scarborough Twitter Account  Ralph Scarborough News  Ralph Scarborough on Facebook
Vice President
Robert Hopkins
  Robert Hopkins LinkedIn Profile  Robert Hopkins Twitter Account  Robert Hopkins News  Robert Hopkins on Facebook
Vice President
Robert Hughes
  Robert Hughes LinkedIn Profile  Robert Hughes Twitter Account  Robert Hughes News  Robert Hughes on Facebook
Vice President
Patrick Martin
  Patrick Martin LinkedIn Profile  Patrick Martin Twitter Account  Patrick Martin News  Patrick Martin on Facebook
Vice President
Justin Rebo
  Justin Rebo LinkedIn Profile  Justin Rebo Twitter Account  Justin Rebo News  Justin Rebo on Facebook
VP - Bus. Development
Peng Leong
  Peng Leong LinkedIn Profile  Peng Leong Twitter Account  Peng Leong News  Peng Leong on Facebook
VP - Regulatory Affairs
Carrie Furr
  Carrie Furr LinkedIn Profile  Carrie Furr Twitter Account  Carrie Furr News  Carrie Furr on Facebook

 

 

Browse more venture capital transactions:

Prev: 2/13/2024: Bob W venture capital transaction
Next: 2/13/2024: Founderful venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.